Top Stories

AJR: Algorithm reduces benign lung biopsy rate

Wednesday, January 25
Lung Cancer - 22.65 Kb

When following a stringent diagnostic protocol in CT lung cancer screening, few biopsies will be recommended and performed on benign nodules, which should alleviate at least some concerns that low-dose CT screening produces a high false-positive rate, according to a study published in the February issue of the American Journal of Roentgenology.

AJR: Breast MR may rule out malignancy, surgery for some with high-risk lesions

Tuesday, January 24
Breast MRI - 32.98 Kb

Women with two types of high-risk lesions (papilloma and radial scar) with normal MRI results can avoid surgical excision and instead undergo clinical and imaging follow-up, according to a prospective study published in the February issue of American Journal of Roentgenology.

AIM: Contrast media adversely affects thyroid function

Monday, January 23
Stop? - 17.70 Kb
Exposure to iodinated contrast media during imaging procedures is associated with changes in thyroid function and an increased risk of hyperthyroidism, according to a report in the Jan. 23 issue of Archives of Internal Medicine. An accompanying commentary argued that the study is a good example of why patients who may be particularly vulnerable to thyroid dysfunction should be monitored after iodine exposure.

AJR: Metrics + motivation sets stage for improved rad safety

Monday, January 23
- 16.81 Kb
Radiology departments must define and monitor their safety metrics to measure departmental performance, identify problem areas and track improvement, while also fostering a supportive department culture, according to an article published in the February issue of the American Journal of Roentgenology.

Radiology: Preop MRI may trim prostate surgery nerve damage risk

Monday, January 23
Prostate Cancer, oncology imaging - 39.47 Kb
Preoperative MRI helped surgeons make more informed decisions about nerve-sparing procedures in men with prostate cancer, according to a study published online Jan. 24 in Radiology.

PORTAL TOPICS

Bone Imaging

Gastrointestinal/Renal Imaging

Lymphoma

Men’s Imaging

Neuroimaging

Pediatric Imaging

Thoracic Imaging

Women’s Imaging

Latest News


Study: MRS may provide diagnostic, prognostic biomarker for brain tumors

Clinical Studies | Friday, January 27
A new magnetic resonance spectroscopy (MRS) technique may offer a method to detect and track a protein associated with a genetic mutation in brain tumor cancer cells. The method could inform diagnosis of glioma and provide prognostic information, according to a study published online Jan. 26 in Nature Medicine.

Study: IMRT boosts quality of life for head and neck cancer patients

Clinical Studies | Friday, January 27
Patients with head and neck cancers who have been treated with intensity-modulated radiation therapy (IMRT) enjoy a better quality of life than those treated with 3D conformal radiation therapy, according to a study presented Jan. 27 at the Multidisciplinary Head and Neck Cancer Symposium in Phoenix.

Shine to build new U.S. plant for moly-99 production

Industry News | Friday, January 27
Shine Medical Technologies, a developer of medical isotopes and cancer treatment elements, intends to build a new manufacturing plant in Janesville, Wis. Plant completion is planned for 2015, with more than 100 permanent employees and potential for further employment growth.

Naviscan scores PEM orders in the EU

Contracts & Installations | Thursday, January 26
Naviscan PET scanners performing positron emission mammography (PEM) have been installed in two European centers: Radiologie und Nuklearmedizin in Ludwigshafen, Germany, and Medica in Istanbul, Turkey.

Herzing U. acquires Medical Technology Management Institute

Mergers & Acquisitions | Wednesday, January 25
Milwaukee-based Herzing University has acquired the Medical Technology Management Institute, which provides continuing education for radiologic technologists and diagnostic medical physicists.

Study: Half of recommended preventive services missed during annual check-ups

Clinical Studies | Tuesday, January 24
- 10.93 Kb
Although 44.4 million adults make it a point to receive periodic health examinations each year, many of them may not be receiving the recommended screening tests and counseling services that could benefit their health, according to a study published January in the American Journal of Preventive Medicine.

Study: Little patient enthusiasm for web-based health improvement tools

Industry News | Monday, January 23
- 19.18 Kb
Internet use among adults has skyrocketed over the past several years and the time may seem ripe for developing web-based tools to help patients manage their health, but research published online Jan. 4 by the Journal of Health Communication suggested that such tools will receive underwhelming attention from patients.

RTOG reveals “practice-changing” marker for brain tumor treatment

Clinical Studies | Friday, January 20
An analysis of clinical trial results performed by the Radiation Therapy Oncology Group (RTOG) demonstrated that a chromosomal abnormality has definitive prognostic and predictive value for managing the treatment of adult patients with pure and mixed anaplastic oligodendrogliomas. "These are exciting and practice-changing results," said Walter J. Curran, Jr., MD, RTOG group chair and executive director of the Winship Cancer Institute of Emory University in Atlanta, in a statement.

JNCI: Younger breast cancer survivors face quality of life issues

Clinical Studies | Thursday, January 19
Breast cancer patients aged 50 or younger experience psychosocial and menopause-related concerns, weight gain and infertility, according to a literature review published Jan. 20 in the Journal of the National Cancer Institute. The researchers called for additional studies and targeted interventions to address these symptoms and concerns.

Bioscan opens subsidiary in France

Industry News | Tuesday, January 17
Bioscan, a developer of preclinical imaging systems, has established a subsidiary in Dijon, France, Bioscan Molecular Imaging France.

JNM: PET has predictive value for triple-negative breast cancer

Clinical Studies | Monday, January 16
An interim 18F-FDG PET/CT exam after two cycles of neoadjuvant chemotherapy was predictive of pathologic response and disease-free survival in patients with triple-negative breast cancer, an aggressive subtype of breast cancer, according to a prospective study published online Jan. 12 in the Journal of Nuclear Medicine.

Johns Hopkins molecular imaging center delves into various cancers

Clinical Studies | Monday, January 16
The team at Johns Hopkins In-Vivo Cellular and Molecular Imaging Center in Baltimore is using novel imaging tools to discover new early detection methods for cancers existing in cells, and study its prevention and elimination before spreading to other organs and tissues.

Most read articles in the past 30 days
test